Qiming & Lilly Asia Fund Pulmonary Hypertension Solutions
03 Mar 2025
US$ 20.00
Qiming Venture Partners and Lilly Asia Ventures (LAV) have co-led the near US$100 million series C financing round ......
Related Publications
Subscribers’ Weekly ending 13 Jun 2025...
Listen to Rest of Asia/Rest of the World Investments (Subscribers' Weekly 13 Jun 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.